GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Shiller PE Ratio

Lexagene Holdings (Lexagene Holdings) Shiller PE Ratio : (As of Jun. 04, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lexagene Holdings Shiller PE Ratio Historical Data

The historical data trend for Lexagene Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Shiller PE Ratio Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lexagene Holdings's Shiller PE Ratio

For the Medical Devices subindustry, Lexagene Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Shiller PE Ratio falls into.



Lexagene Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lexagene Holdings's E10 for the quarter that ended in Nov. 2022 is calculated as:

For example, Lexagene Holdings's adjusted earnings per share data for the three months ended in Nov. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Nov. 2022 (Change)*Current CPI (Nov. 2022)
=-0.01/125.6074*125.6074
=-0.010

Current CPI (Nov. 2022) = 125.6074.

Lexagene Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 -0.010 96.871 -0.013
201303 -0.043 98.209 -0.055
201306 -0.095 98.518 -0.121
201309 -0.010 98.790 -0.013
201312 -0.066 98.326 -0.084
201403 -0.086 99.695 -0.108
201406 0.066 100.560 0.082
201409 -0.027 100.428 -0.034
201412 -0.009 99.070 -0.011
201503 -0.007 99.621 -0.009
201506 -0.002 100.684 -0.002
201509 -0.002 100.392 -0.003
201512 -0.003 99.792 -0.004
201603 -0.009 100.470 -0.011
201606 -0.008 101.688 -0.010
201609 -0.008 101.861 -0.010
201702 -0.010 102.779 -0.012
201705 -0.010 103.256 -0.012
201708 -0.010 103.587 -0.012
201711 -0.030 104.072 -0.036
201802 -0.030 105.052 -0.036
201805 -0.030 106.148 -0.035
201808 -0.030 106.383 -0.035
201811 -0.030 106.338 -0.035
201902 -0.030 106.649 -0.035
201905 -0.030 108.048 -0.035
201908 -0.020 108.245 -0.023
201911 -0.040 108.519 -0.046
202002 -0.020 109.139 -0.023
202005 -0.030 108.175 -0.035
202008 -0.020 109.662 -0.023
202011 -0.030 109.793 -0.034
202102 -0.020 110.968 -0.023
202105 -0.020 113.576 -0.022
202108 -0.020 115.421 -0.022
202111 -0.020 117.269 -0.021
202202 -0.020 119.703 -0.021
202205 -0.020 123.323 -0.020
202208 -0.020 124.958 -0.020
202211 -0.010 125.607 -0.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lexagene Holdings  (OTCPK:LXXGQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lexagene Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.